Company Overview of Avion Pharmaceuticals, LLC
Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, develops and markets a portfolio of pharmaceutical and dietary supplement products in the women’s heath and dermatology therapeutic areas. It offers Prenate, which improves the nutritional status of women throughout pregnancy and in the postnatal period for lactating and non-lactating mothers; Nicomide, which contains niacin, zinc, and folic acid, and addresses the inflammatory response before acne lesions; and PRENATE MINI, a blended vitamin incorporating QUATREFOLIC, DHA, 13 vitamins and minerals, and 25mg of blueberry extract. The company also provides PRENATE DHA, a blended vitamin incorporating QUATREFOLIC, DHA, and 8 vitam...
8505 Dunwoody Place
Atlanta, GA 30350
Founded in 2010
Key Executives for Avion Pharmaceuticals, LLC
Chief Executive Officer and Chief Operation Officer
Compensation as of Fiscal Year 2017.
Avion Pharmaceuticals, LLC Key Developments
Avion Pharmaceuticals, LLC Announces Approval of First NDA in the Oral Contraceptive Category
Jan 17 18
Avion Pharmaceuticals, LLC received approval of its new drug application (NDA) for the oral contraceptive Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), the company's first internally developed NDA. Avion expects to commercially launch this new oral contraceptive to the prescribing community in Spring 2018. The approval of Balcoltra, the only branded oral contraceptive combining 0.1 mg levonorgestrel, 20 mcg ethinyl estradiol tablets and ferrous bisglycinate tablets 36.5 mg, marks a milestone for Avion Pharmaceuticals and a win for the women's health category by allowing women to have access to a clinically effective form of oral contraception for pregnancy prevention.
Avion Pharmaceuticals, LLC Renews Ongoing Partnership with Gnosis, S.P.A., to License Quatrefolic, Body-Ready Folate, through Patent Life of 2028
Aug 16 16
Avion Pharmaceuticals, LLC recently announced it has solidified its continuing partnership with Gnosis S.P.A. to provide Quatrefolic®, the fourth-generation folate, as part of the Prenate® prescription prenatal vitamin portfolio. As a result of the recent agreement, Avion will provide Quatrefolic® through the duration of its patent life, which runs through 2028. Quatrefolic® ((6S)-5 methyltetrahydrofolate glucosamine salt) is a patented and unique body-ready form of folate that is an important component of prenatal nutritional support for both expecting mothers or women trying to conceive. Folic acid helps prevent neural tube defects (NTD) such as spina bifida. Up to 50% of American women have MTHFR polymorphism, which does not allow the body to metabolize folic acid that is available through diet or nutritional supplements. 1,2 Quatrefolic® folate, available in all Prenate® prescription prenatals, is delivered in the form that is already in the biologically active form for the body to use and overcomes the MTHFR polymorphism common in women allowing all women, regardless of their genetic predisposition, to absorb folate and enjoy the protective benefits as they prepare for motherhood.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|